Ninety-four per cent of life sciences companies planning an acquisition in the next year
A global study of 100 senior executives at life sciences companies by global law firm Reed Smith, in partnership with Mergermarket, reveals that 94 per cent are planning to make an acquisition in the next year. A further 87 per cent are expecting these to be cross-border transactions. The
